循环细胞因子水平和中风后5年血管复发:一个多中心前性队列研究
Lanyue Zhang1, Mohamad Ali Antabi1, Jana Mattar1
1Institute for Stroke and Dementia Research (ISD), LMU University Hospital, LMU Munich, Munich, Germany.
European stroke journal
|August 12, 2025
概括
在急性中风患者中CD62E和MIF的较高水平预测了复发性中风或TIA的更高风险. 这些炎症生物标志物改善了对二次中风预防的风险预测.
科学领域:
- 心血管医学 心血管医学
- 炎症研究 炎症研究
- 脑卒中神经学 脑卒中神经学
背景情况:
- 二次中风预防策略对于减少血管复发至关重要.
- 识别炎症生物标志物可以优化对抗炎症临床试验的患者选择.
- 目前的中风复发风险预测模型可能无法完全捕捉炎症贡献.
研究的目的:
- 调查急性中风患者血炎性细胞因子水平与随后血管事件的风险之间的关联.
- 为了确定特定的细胞因子是否可以改善复发性中风或短暂性缺血性发作 (TIA) 的预测.
主要方法:
- 一项多中心前性队列研究,涉及486名急性中风患者.
- 在中风发作后3天的中位数测量了22种血炎性细胞因子.
- 5年的随访记录了复发性中风/TIA和复合血管事件,使用经过风险因素调整的考克斯模型进行分析.
主要成果:
- 较高的急性期血水平CD62E和MIF显着与复发性中风或TIA的风险增加有关 (aHR分别为1.63和1.56).
- 在细胞因子水平和复发事件风险之间观察到剂量反应关系.
- 包括CD62E和MIF水平显著改善了超过传统风险因素和CRP的5年复发性中风/TIA风险的预测.
结论:
- 基线CD62E和MIF水平的升高是最初事件发生后5年内复发性中风或TIA的独立预测因素.
- 这些细胞因子提高了二次中风预防现有风险分层模型的预测准确度.
- 需要进行进一步的研究,以探索CD62E和MIF在选择二次中风预防试验中的患者接受抗炎疗法的实用性.
更多相关视频
08:23Isolation and Flow Cytometric Assessment of Neuroimmune Interactions in a Mini-Stroke Murine Model
Published on: June 20, 2025
147
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
3.5K
相关概念视频
01:27Regulation of Stroke Volume
3.5K
The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
3.5K
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
35
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
35
01:26Atherosclerosis III: Management
35
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
35
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
334
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
334
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
214
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
214
01:30Acute Coronary Syndrome III: Diagnostic Studies
23
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23